(Q33536294)

27 July 2017

1 reference

title

Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone. (English)

1 reference

27 July 2017

main subject

multiple drug resistance

1 reference

1 reference

Pilarski LM

1

1 reference

27 July 2017

Mant MJ

series ordinal

2

1 reference

27 July 2017

Belch AR

series ordinal

3

1 reference

27 July 2017

publication date

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

32

1 reference

27 July 2017

issue

3-4

1 reference

27 July 2017

page(s)

199-210

1 reference

Unlocking vaults: organelles in search of a function

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Vaults are the answer, what is the question?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Treatment of Plasma Cell Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Reassessment of the relationship between M-protein decrement and survival in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

The biochemistry of P-glycoprotein-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Modifiers of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Multidrug transporter p‐glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Analysis of multidrug‐resistance (MDR‐1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Antibody diversity: a case for its generation after antigenic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

Generation of antibody dieversity. IV. Variation within single clones of antibody-forming cells developingin vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199909167381

10.3109/10428199909167381

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference